MiR-1294 inhibits the progression of breast cancer via regulating ERK signaling.

Bull Cancer

Ningde Municipal Hospital of Ningde Normal University, Department of Oncology Surgery, Ningde, Fujian, People's Republic of China. Electronic address:

Published: October 2022

Breast cancer (BC) is the most diagnosed carcinoma in women worldwide, which is characterized with a high incidence rate and poor prognosis. MicroRNAs (miRNAs) are promising biomarkers for early detection of BC. In this study, we demonstrated that MiR1294 was downregulated in BC. Moreover, we revealed that MiRNA1294 significantly suppressed cell proliferation, migration and invasion. Animal models revealed that MiRNA1294 reduced tumor formation. In addition, we found that ERK signaling was involved in the regulatory role of MiRNA1294 in BC. In conclusion, MiRNA1294 acted as a tumor suppressor in BC, which might serve as a potential target for the development of anti-neoplastic therapies in BC.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2022.02.017DOI Listing

Publication Analysis

Top Keywords

breast cancer
8
revealed mirna1294
8
mir-1294 inhibits
4
inhibits progression
4
progression breast
4
cancer regulating erk
4
regulating erk signaling
4
signaling breast
4
cancer diagnosed
4
diagnosed carcinoma
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!